Blockchain To Be Used To Improve Medical Trials, Omnitude and Clinical Connex partner

Blockchain To Be Used To Improve Medical Trials, Omnitude and Clinical Connex partner

Clinical Drug Trials Aim To Take Maximum Advantage of Blockchain Revolution

Omnitude, one of the fastest growing UK technology businesses announced today the signing of a pharmaceutical commercial contract to develop a blockchain solution that will bring greater trust, security and efficacy to clinical drug trials in the UK and USA.

Clinical Connex, a UK registered Pan-Atlantic business has confirmed the commencement of development on a brand new blockchain-enabled platform that will transform the way some of the world’s largest pharmaceutical businesses conduct clinical trials.

Utilising Omnitude’s widely regarded blockchain architecture and Self-Sovereign Identity (SSI), Clinical Connex intend to offer a ‘best-in-class’ alternative process and procedure to the existing trial methodology, ensuring greater accuracy and transparency in results testing.

The contract is worth an estimated $30 million, over a 5-year period. This is a great win for the UK technology company Omnitude, formed just 18 months ago and winning some of the most reputable International businesses whilst diligently building their technology platform. Omnitude are members of The Linux Foundation, Hyperledger and Tech UK.

“This major milestone is testament to Omnitude’s dedication to enabling real- world advantage to future-focused businesses who embrace this new disruptive technology. With Clinical Connex, we share the same vision for bringing simplicity and clarity to an ever increasing complex technological world and we are both excited at the prospect of bringing the benefits of blockchain technology to the clinical drug trials industry.” Chris Painter, Founder CEO – Omnitude.

Omnitude has grown from a passionate idea into an International tech pioneer within just 18 months. They are focused on building flexible integrated blockchain solutions using their core platform, catering for Life Sciences, Supply Chain Management and Data/Identity Security. Omnitude’s solutions are unique, ingenious and practical. Their core mission, to provide real-world pragmatic value through emerging technology. They have already forged international partnerships, including; Capita Plc, CS-Cart, The Maltese Government Ministry for Transport, Infrastructure and Capital Projects to name a few.

For more information contact or visit press@omnitude.tech omnitude.tech

More information about Irish Tech News and the Business Showcase

FYI the ROI for you is => Irish Tech News now gets over 1.5 million monthly views, and up to 900k monthly unique visitors, from over 160 countries. We have over 860,000 relevant followers on Twitter on our various accounts & were recently described as Ireland’s leading online tech news site and Ireland’s answer to TechCrunch, so we can offer you a good audience!

Since introducing desktop notifications a short time ago, which notify readers directly in their browser of new articles being published, over 16000 people have now signed up to receive them ensuring they are instantly kept up to date on all our latest content. Desktop notifications offer a unique method of serving content directly to verified readers and bypass the issue of content getting lost in people’s crowded news feeds.

Drop us a line if you want to be featured, guest post, suggest a possible interview, or just let us know what you would like to see more of in our future articles. We’re always open to new and interesting suggestions for informative and different articles. Contact us, by email, twitter or whatever social media works for you and hopefully we can share your story too and reach our global audience.

If you would like to have your company featured in the Irish Tech News Business Showcase, get in contact with us at Simon@IrishTechNews.ie or on Twitter: @SimonCocking